drugset / Trial / NCT00442403

Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria

NCT00442403 ↗

Phase 3 Suspended 200 enrolled Université Victor Segalen Bordeaux 2
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the safety and efficacy of a standard chloroquine drug regimen administration supplemented with dehydroepiandrosterone sulfate against drug-resistant malaria.

Timeline

Start
2002-04
Primary completion
—
Completion
2002-09

Outcome

Outcome not reported

Stopped: “At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line therapy for of uncomplicated malaria.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule — —
Subject Dehydroepiandrosterone Other / unclassified — —